or Try an Advanced Search...

    Technical Analysis for EYEN - Eyenovia, Inc.

    Grade Last Price % Change Price Change
    F 0.82 -23.11% -0.25
    EYEN closed up 28.28 percent on Wednesday, May 15, 2024, on 2.05 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical EYEN trend table...
    Date Alert Name Type % Chg
    Crossed Above 50 DMA Bullish -23.11%
    MACD Bullish Centerline Cross Bullish -23.11%
    Pocket Pivot Bullish Swing Setup -23.11%
    Earnings Movers Other -23.11%
    Wide Bands Range Expansion -23.11%
    Gapped Up Strength -23.11%
    Up 3 Days in a Row Strength -23.11%
    Upper Bollinger Band Touch Strength -23.11%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.37%
    Wide Bands Range Expansion -1.37%
    Older End-of-Day Signals for EYEN ...

       Recent Intraday Alerts

    Alert Time
    2x Volume Pace about 1 hour ago
    1.5x Volume Pace about 1 hour ago
    3x Volume Pace about 1 hour ago
    Down 2 ATRs about 1 hour ago
    10 DMA Resistance about 2 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    EYEN Chart by TradingView
    Basic chart:

    Profile

    Eyenovia Inc is a clinical stage biopharmaceutical company. It is engaged in developing a pipeline of ophthalmology products utilizing patented piezo-print technology to deliver micro-therapeutics topically to the eye.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Eye Ophthalmology Ophthalmology Products

    Is EYEN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 16 Eyenovia Inc (EYEN) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and ...
    May 15 Eyenovia GAAP EPS of -$0.23
    May 15 Eyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III Program and its Two FDA Approved Commercial Products, Mydcombi and Clobetasol
    May 14 Eyenovia to Report First Quarter 2024 Results on Wednesday, May 15th
    May 10 Formosa and Tabuk sign deal for FDA-approved ophthalmic suspension
    Apr 25 Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi™ and Clobetasol Propionate Ophthalmic Suspension
    Apr 9 Eyenovia (EYEN) Down 18% on Disappointing Corporate Update
    Apr 8 Eyenovia Announces Updated Strategy and Corporate Priorities to Focus on Shareholder Value Generation and Immediate Commercial Opportunities
    Apr 3 Eyenovia to Feature its Suite of Commercial Products and the Optejet Dispenser at Upcoming National Eyecare Meetings
    Mar 27 Q4 2023 NovaBay Pharmaceuticals Inc Earnings Call
    See more EYEN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.59
    52 Week Low 0.501
    Average Volume 1,396,785
    200-Day Moving Average 1.51
    50-Day Moving Average 0.96
    20-Day Moving Average 0.76
    10-Day Moving Average 0.88
    Average True Range 0.13
    RSI (14) 61.39
    ADX 28.26
    +DI 36.16
    -DI 14.87
    Chandelier Exit (Long, 3 ATRs) 0.76
    Chandelier Exit (Short, 3 ATRs) 0.89
    Upper Bollinger Bands 1.08
    Lower Bollinger Band 0.45
    Percent B (%b) 0.97
    BandWidth 82.39
    MACD Line 0.00
    MACD Signal Line -0.04
    MACD Histogram 0.0405
    Fundamentals Value
    Market Cap 46.77 Million
    Num Shares 44.1 Million
    EPS -0.66
    Price-to-Earnings (P/E) Ratio -1.61
    Price-to-Sales 67398.69
    Price-to-Book 5.14
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.36
    Resistance 3 (R3) 1.33 1.20 1.31
    Resistance 2 (R2) 1.20 1.13 1.22 1.29
    Resistance 1 (R1) 1.13 1.08 1.17 1.16 1.27
    Pivot Point 1.01 1.01 1.03 1.02 1.01
    Support 1 (S1) 0.94 0.93 0.97 0.96 0.85
    Support 2 (S2) 0.81 0.89 0.82 0.83
    Support 3 (S3) 0.74 0.81 0.81
    Support 4 (S4) 0.76